Edgewise Therapeutics (EWTX) Enterprise Value Growth (1y) (2021 - 2026)
Edgewise Therapeutics (EWTX) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Edgewise Therapeutics | 4.21 Bn | 4.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.47% |
| Dec 31, 2025 | -46.76% |
| Sep 30, 2025 | -14.38% |
| Jun 30, 2025 | 0.19% |
| Mar 31, 2025 | 90.63% |
| Dec 31, 2024 | 51.61% |
| Sep 30, 2024 | -1,394.37% |
| Jun 30, 2024 | -36.72% |
| Mar 31, 2024 | -1,004.71% |
| Dec 31, 2023 | -291.47% |
| Sep 30, 2023 | 69.97% |
| Jun 30, 2023 | 87.20% |
| Mar 31, 2023 | -39.99% |
| Dec 31, 2022 | -41.29% |
| Sep 30, 2022 | 62.22% |
| Jun 30, 2022 | 16.98% |
| Mar 31, 2022 | 84.41% |
| Dec 31, 2021 | 85.16% |
| Sep 30, 2021 | -650.05% |
| Jun 30, 2021 | -1,673.88% |